Clinical Trial Update: First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors [Phase 1]

View source ↗

Summary

First-in-human Phase 1 trial evaluating CDR404 in HLA-A*02:01 participants with MAGE-A4 expressing solid tumors is currently recruiting. The study is sponsored …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• CDR404

Snippet

Sponsor: CDR-Life AG | Conditions: Select Advanced Solid Tumors | Phase 1 | Status: RECRUITING